Ohio molecular imaging firm hopes to improve cancer detection
Molecular imaging company Enlyton Ltd. is looking for a $3 million investment to get its cancer-detection technology into clinical studies. The company believes its targeting agent, an antibody called ATA-1, is better than the industry standard at making cancerous tumors stand out in medical imaging scans.